Market Outlook
The global Equine Veterinary Therapeutics market size was valued at USD 1294.4 million in 2022 and is forecast to a readjusted size of USD 2012.5 million by 2029 with a CAGR of 6.5% during review period.
Equine Veterinary Therapeutics refers to the specialized field of veterinary medicine that focuses on the diagnosis, treatment, and management of health issues and injuries in horses. This branch of veterinary science encompasses a wide range of therapeutic interventions, including medical, surgical, and rehabilitative approaches, all aimed at maintaining the health, well-being, and performance of equines. Equine veterinary therapeutics play a crucial role in ensuring the overall health and longevity of horses, whether they are involved in sports and competition or serve as companion animals.
A significant driver in the Equine Veterinary Therapeutics market is the growing demand for high-quality healthcare and treatment options for horses. As the importance of equines in various sectors, including sports, agriculture, and leisure, continues to rise, there is an increased emphasis on maintaining their health and performance. This drives the demand for innovative veterinary therapeutics, such as advanced medications, surgical techniques, and rehabilitation methods, to address a wide range of equine health issues. One of the key challenges in this market is the cost associated with advanced equine veterinary care. High-end treatments, specialized surgeries, and cutting-edge therapies can be expensive, which may limit access for some horse owners or require substantial investments. Additionally, ensuring the safety and effectiveness of equine therapeutics can be challenging due to the size and unique physiology of horses, requiring specialized expertise and equipment. Regulatory compliance and ensuring the welfare of the animals also pose ongoing challenges in this industry.
Report includes an overview of the development of the Equine Veterinary Therapeutics industry chain, the market status of Veterinary Hospital (Drugs, Vaccine), Veterinary Clinics (Drugs, Vaccine), and key enterprises in developed and developing market, and analyzed the cutting-edge technology, patent, hot applications and market trends of Equine Veterinary Therapeutics.
Regionally, the report analyzes the Equine Veterinary Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Equine Veterinary Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Equine Veterinary Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Equine Veterinary Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Drugs, Vaccine).
Industry Analysis: Report analyze the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Equine Veterinary Therapeutics market.
Regional Analysis: The report involves examining the Equine Veterinary Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behavior to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Equine Veterinary Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Equine Veterinary Therapeutics:
Company Analysis: Report covers individual Equine Veterinary Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behavior, preferences, and attitudes towards Equine Veterinary Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Veterinary Hospital, Veterinary Clinics).
Technology Analysis: Report covers specific technologies relevant to Equine Veterinary Therapeutics. It assesses the current state, advancements, and potential future developments in Equine Veterinary Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Equine Veterinary Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Key Market Players
Boehringer Ingelheim
Merck Animal Health
Zoetis
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Segmentation By Type
Drugs
Vaccine
Other
Segmentation By Application
Veterinary Hospital
Veterinary Clinics
Other
Segmentation By Region
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Market SWOT Analysis
What are the strengths of the Equine Veterinary Therapeutics Market in 2025?
The market benefits from increasing awareness and investment in equine health, with a growing demand for advanced therapies and treatments. Additionally, the rise in equestrian sports and recreational riding is driving demand for specialized veterinary care. Technological advancements, like innovative diagnostic tools and therapeutic methods, are also a major strength, improving treatment outcomes for equine animals.
What weaknesses are present in the Equine Veterinary Therapeutics Market in 2025?
A significant challenge is the high cost of advanced therapeutics and treatments, which may limit access for smaller veterinary practices or owners of non-competitive horses. Regulatory hurdles and lengthy approval processes for new medications also slow market growth. Additionally, there remains a gap in skilled professionals, such as veterinary specialists focused on equine care.
What opportunities exist in the Equine Veterinary Therapeutics Market in 2025?
Opportunities lie in the increasing adoption of biologics, regenerative medicine, and stem cell therapies, which are becoming more popular in equine treatment. There's also growing potential in emerging markets where equine sports and industries are expanding. Partnerships between pharmaceutical companies and veterinary hospitals to innovate new therapeutics present additional growth avenues.
What threats could impact the Equine Veterinary Therapeutics Market in 2025?
Potential threats include economic downturns that could lead to reduced spending on equine healthcare. Moreover, competition from generic drug manufacturers might pressure prices. Ethical concerns around certain treatments and the risk of disease outbreaks that could affect the global equine population also pose threats to market stability.
Market PESTEL Analysis
What political factors affect the Equine Veterinary Therapeutics Market in 2025?
Government regulations and policies regarding animal health, drug approval processes, and veterinary practices significantly influence the market. Strict regulatory frameworks for pharmaceutical development, especially for new therapeutics, can create barriers to entry but also ensure safety and efficacy. Policies related to animal welfare and veterinary education also impact market dynamics.
How do economic factors influence the Equine Veterinary Therapeutics Market in 2025?
Economic conditions play a crucial role in determining consumer spending on equine healthcare. During economic downturns, horse owners may cut back on non-essential treatments or opt for more affordable options. Additionally, the price of therapeutic products and treatments can be affected by inflation and the cost of raw materials, influencing both supply and demand.
What social factors are important for the Equine Veterinary Therapeutics Market in 2025?
There is an increasing trend towards animal welfare and care, driving demand for better veterinary therapeutics. Social interest in equestrian sports and recreational horse riding continues to grow, promoting awareness of equine health. Furthermore, the changing attitudes towards animal treatment, with a greater focus on alternative and holistic therapies, is shaping market trends.
How do technological factors impact the Equine Veterinary Therapeutics Market in 2025?
Technological advancements in diagnostic tools, treatment devices, and drug development processes are reshaping the equine therapeutics landscape. Innovations in regenerative medicine, stem cell therapy, and advanced imaging techniques offer new, effective treatment options. Additionally, the integration of telemedicine and digital health solutions is enhancing veterinary care accessibility and efficiency.
What environmental factors should be considered in the Equine Veterinary Therapeutics Market in 2025?
Sustainability concerns are increasingly important, with more focus on eco-friendly and ethically sourced therapeutic products. The impact of climate change on animal health, including the prevalence of certain diseases or pests, could drive demand for specific veterinary therapeutics. Environmental regulations concerning waste disposal from pharmaceutical manufacturing processes also play a role.
How do legal factors affect the Equine Veterinary Therapeutics Market in 2025?
Legal regulations concerning the approval and distribution of veterinary drugs are critical for market operations. Compliance with international standards for drug safety, efficacy, and environmental impact is necessary for market entry. Legal concerns around intellectual property rights and patent expirations of key therapeutics also influence market competition and pricing.
Market SIPOC Analysis
Who are the suppliers in the Equine Veterinary Therapeutics Market in 2025?
Suppliers include pharmaceutical companies that manufacture therapeutic drugs, biologics, and diagnostic tools for equine care. Additionally, suppliers of raw materials for drug production, equipment for veterinary clinics, and providers of advanced technologies, such as regenerative medicine components, also contribute to the market.
What inputs are required in the Equine Veterinary Therapeutics Market in 2025?
Key inputs include active pharmaceutical ingredients (APIs), veterinary care infrastructure, advanced diagnostic tools, and trained veterinary professionals. Research and development investments, as well as regulatory approvals, are also critical inputs for bringing new therapeutics to market.
Who are the process owners in the Equine Veterinary Therapeutics Market in 2025?
Process owners typically include veterinary pharmaceutical companies responsible for product development, testing, and marketing. Veterinary professionals such as equine specialists and clinic owners also manage the processes of diagnosis, treatment administration, and follow-up care. Regulatory bodies oversee the approval and compliance processes to ensure safety and efficacy.
Who are the customers in the Equine Veterinary Therapeutics Market in 2025?
Customers include horse owners, veterinarians, equestrian sports organizations, and equine research institutions. These customers seek a range of therapeutic products, including pain management, vaccines, and advanced treatments like stem cell therapies for their horses' health.
What are the outputs of the Equine Veterinary Therapeutics Market in 2025?
The outputs are a range of veterinary therapeutics, including vaccines, pain relief medications, anti-inflammatory drugs, and regenerative treatments such as stem cell and platelet-rich plasma therapies. These products are designed to enhance equine health, improve performance, and treat a variety of diseases and injuries.
Market Porter's Five Forces
How strong is the threat of new entrants in the Equine Veterinary Therapeutics Market in 2025?
The threat of new entrants is moderate. While the market offers growth opportunities, high regulatory barriers, significant capital investment, and the need for specialized knowledge in equine therapeutics make it difficult for new companies to enter easily. Established players with strong R&D capabilities and distribution networks hold a competitive advantage.
How intense is the bargaining power of suppliers in the Equine Veterinary Therapeutics Market in 2025?
The bargaining power of suppliers is moderate. While there are key suppliers for pharmaceutical ingredients and specialized equine therapeutics, the market has a wide variety of suppliers for many of these inputs. However, specialized suppliers of biologics or advanced technologies may have higher power due to limited alternatives.
How strong is the bargaining power of buyers in the Equine Veterinary Therapeutics Market in 2025?
The bargaining power of buyers is moderate to high. Large veterinary clinics, equine sports organizations, and institutional buyers may have stronger negotiating power due to their purchasing volume. However, individual horse owners have limited power due to the specialized nature of equine therapeutics and the necessity of certain treatments.
What is the threat of substitute products in the Equine Veterinary Therapeutics Market in 2025?
The threat of substitutes is moderate. While there are alternative treatments such as holistic or herbal therapies, conventional veterinary therapeutics are still preferred due to their proven effectiveness. However, as new, non-pharmaceutical solutions such as regenerative medicine and alternative therapies grow, the threat of substitutes may increase.
How intense is the competitive rivalry in the Equine Veterinary Therapeutics Market in 2025?
Competitive rivalry is high. The market is growing, with numerous players competing in the development and sale of equine-specific therapeutic products. Additionally, larger pharmaceutical companies are expanding into this space, increasing competition for market share. The race for innovation in therapeutics and technological advancements adds to the rivalry.
Market Upstream Analysis
What are the key raw materials required for the Equine Veterinary Therapeutics Market in 2025?
Key raw materials include active pharmaceutical ingredients (APIs), biologic components like stem cells or growth factors, excipients for drug formulation, and medical devices for therapeutic administration. These materials are essential for producing effective therapeutic products tailored for equine health.
What role do suppliers of raw materials play in the Equine Veterinary Therapeutics Market in 2025?
Suppliers of raw materials play a critical role by providing the necessary inputs for drug development and manufacturing. The quality, availability, and cost of these materials directly impact the production of veterinary therapeutics, ensuring that treatments are both effective and compliant with regulatory standards.
How do regulatory agencies influence the upstream activities in the Equine Veterinary Therapeutics Market in 2025?
Regulatory agencies significantly impact upstream activities by setting strict guidelines for the approval of new drugs, vaccines, and treatments. They ensure that all raw materials and production processes meet safety and efficacy standards, which influences sourcing, manufacturing practices, and innovation in therapeutics.
How does research and development (R&D) affect the upstream sector in the Equine Veterinary Therapeutics Market in 2025?
R&D is pivotal in the upstream sector, as it drives innovation in therapeutic solutions. The development of new treatments, such as biologics and regenerative medicine, depends on extensive research, influencing the sourcing of novel raw materials and advanced technologies. R&D also determines the future direction of therapeutic offerings based on unmet needs in equine healthcare.
What challenges exist for upstream players in the Equine Veterinary Therapeutics Market in 2025?
Upstream players face challenges such as rising costs of raw materials, especially for specialized biologics and regenerative products. Additionally, maintaining compliance with stringent regulatory requirements, ensuring consistent quality, and managing supply chain disruptions can pose significant hurdles. There is also pressure to innovate in line with evolving market demands.
Market Midstream Analysis
What role do manufacturers play in the Equine Veterinary Therapeutics Market in 2025?
Manufacturers are responsible for transforming raw materials into final therapeutic products. They ensure that the production process meets regulatory standards, maintains product quality, and delivers innovative treatments for equine health. Manufacturing also involves packaging, labeling, and distribution, ensuring that products reach veterinary clinics and healthcare providers efficiently.
How does distribution impact the Equine Veterinary Therapeutics Market in 2025?
Distribution is key to ensuring that therapeutic products reach their end-users—veterinarians, clinics, and horse owners. A well-organized distribution network, including wholesalers, retail outlets, and direct sales channels, is crucial for timely delivery and maintaining product availability. Distribution also influences product pricing, with logistics costs impacting the final price point.
What challenges do midstream players face in the Equine Veterinary Therapeutics Market in 2025?
Midstream players face challenges such as maintaining supply chain efficiency, managing inventory, and navigating regulatory compliance in different markets. There may also be fluctuations in demand, especially for specialized treatments, which can complicate production scheduling and inventory management. Furthermore, dealing with the evolving complexities of cold-chain logistics for biologics can be a challenge.
How do regulatory and quality control standards affect the midstream sector in the Equine Veterinary Therapeutics Market in 2025?
Regulatory and quality control standards play a significant role in the midstream sector, as they ensure that products are safe, effective, and compliant with local laws. Midstream players must adhere to stringent guidelines for manufacturing, packaging, and distribution to prevent contamination or errors. Non-compliance can result in costly delays, recalls, or loss of market access.
How does innovation in manufacturing technologies influence the Equine Veterinary Therapeutics Market in 2025?
Innovation in manufacturing technologies, such as automation, biotechnology, and advanced production techniques, can enhance efficiency, reduce costs, and improve product quality. New manufacturing technologies also enable the development of more complex therapeutics, such as biologics and gene therapies, that meet the evolving needs of equine healthcare. This innovation is crucial for staying competitive in the growing market.
Market Downstream Analysis
What role do veterinarians and clinics play in the Equine Veterinary Therapeutics Market in 2025?
Veterinarians and clinics are central to the downstream sector as they are responsible for diagnosing conditions, recommending treatments, and administering therapies to horses. They are the direct point of contact for equine owners and play a critical role in selecting the right therapeutics based on the individual needs of the animal.
How does the end-user (horse owners, trainers, equestrian organizations) impact the Equine Veterinary Therapeutics Market in 2025?
End-users, including horse owners, trainers, and equestrian organizations, drive demand for specific therapeutics based on the health needs of their horses. Their preferences for certain treatment types, such as regenerative medicine or pain management, influence which products are in high demand. Their willingness to invest in high-quality, specialized treatments also impacts market growth.
What challenges do downstream players face in the Equine Veterinary Therapeutics Market in 2025?
Downstream players face challenges such as the high cost of advanced therapeutics, which can limit access for certain horse owners. Additionally, ensuring timely and accurate diagnosis, along with selecting the right treatment, requires continuous education and access to up-to-date information. Another challenge is managing client expectations, especially when dealing with complex or long-term treatments.
How does regulatory oversight affect the downstream sector in the Equine Veterinary Therapeutics Market in 2025?
Regulatory oversight impacts the downstream sector by setting guidelines for how therapeutics are administered, ensuring that treatments are safe and effective for use. Veterinarians and clinics must comply with these regulations, including the proper documentation and handling of medications, to avoid penalties and ensure the health of the horses under their care.
What trends in consumer behavior are influencing the Equine Veterinary Therapeutics Market in 2025?
Consumers are increasingly prioritizing the welfare of their horses, seeking out advanced, evidence-based treatments like biologics and regenerative therapies. There is also a growing demand for holistic and preventive care, driving interest in alternative therapies alongside traditional treatments. Additionally, consumers are becoming more informed and selective about the types of therapeutics they choose, based on cost, efficacy, and ethical considerations.
Chapter 1, to describe Equine Veterinary Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Equine Veterinary Therapeutics, with revenue, gross margin and global market share of Equine Veterinary Therapeutics from 2018 to 2023.
Chapter 3, the Equine Veterinary Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Equine Veterinary Therapeutics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Equine Veterinary Therapeutics.
Chapter 13, to describe Equine Veterinary Therapeutics research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Equine Veterinary Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Equine Veterinary Therapeutics by Type
1.3.1 Overview: Global Equine Veterinary Therapeutics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Equine Veterinary Therapeutics Consumption Value Market Share by Type in 2022
1.3.3 Drugs
1.3.4 Vaccine
1.3.5 Other
1.4 Global Equine Veterinary Therapeutics Market by Application
1.4.1 Overview: Global Equine Veterinary Therapeutics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Veterinary Hospital
1.4.3 Veterinary Clinics
1.4.4 Other
1.5 Global Equine Veterinary Therapeutics Market Size & Forecast
1.6 Global Equine Veterinary Therapeutics Market Size and Forecast by Region
1.6.1 Global Equine Veterinary Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Equine Veterinary Therapeutics Market Size by Region, (2018-2029)
1.6.3 North America Equine Veterinary Therapeutics Market Size and Prospect (2018-2029)
1.6.4 Europe Equine Veterinary Therapeutics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Equine Veterinary Therapeutics Market Size and Prospect (2018-2029)
1.6.6 South America Equine Veterinary Therapeutics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Equine Veterinary Therapeutics Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business
2.1.3 Boehringer Ingelheim Equine Veterinary Therapeutics Product and Solutions
2.1.4 Boehringer Ingelheim Equine Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Boehringer Ingelheim Recent Developments and Future Plans
2.2 Merck Animal Health
2.2.1 Merck Animal Health Details
2.2.2 Merck Animal Health Major Business
2.2.3 Merck Animal Health Equine Veterinary Therapeutics Product and Solutions
2.2.4 Merck Animal Health Equine Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck Animal Health Recent Developments and Future Plans
2.3 Zoetis
2.3.1 Zoetis Details
2.3.2 Zoetis Major Business
2.3.3 Zoetis Equine Veterinary Therapeutics Product and Solutions
2.3.4 Zoetis Equine Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Zoetis Recent Developments and Future Plans
2.4 Elanco Animal Health
2.4.1 Elanco Animal Health Details
2.4.2 Elanco Animal Health Major Business
2.4.3 Elanco Animal Health Equine Veterinary Therapeutics Product and Solutions
2.4.4 Elanco Animal Health Equine Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Elanco Animal Health Recent Developments and Future Plans
2.5 Dechra Veterinary Products
2.5.1 Dechra Veterinary Products Details
2.5.2 Dechra Veterinary Products Major Business
2.5.3 Dechra Veterinary Products Equine Veterinary Therapeutics Product and Solutions
2.5.4 Dechra Veterinary Products Equine Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Dechra Veterinary Products Recent Developments and Future Plans
2.6 CEVA
2.6.1 CEVA Details
2.6.2 CEVA Major Business
2.6.3 CEVA Equine Veterinary Therapeutics Product and Solutions
2.6.4 CEVA Equine Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 CEVA Recent Developments and Future Plans
2.7 Virbac
2.7.1 Virbac Details
2.7.2 Virbac Major Business
2.7.3 Virbac Equine Veterinary Therapeutics Product and Solutions
2.7.4 Virbac Equine Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Virbac Recent Developments and Future Plans
2.8 Norbrook Equine
2.8.1 Norbrook Equine Details
2.8.2 Norbrook Equine Major Business
2.8.3 Norbrook Equine Equine Veterinary Therapeutics Product and Solutions
2.8.4 Norbrook Equine Equine Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Norbrook Equine Recent Developments and Future Plans
2.9 Kyoritsu Seiyaku
2.9.1 Kyoritsu Seiyaku Details
2.9.2 Kyoritsu Seiyaku Major Business
2.9.3 Kyoritsu Seiyaku Equine Veterinary Therapeutics Product and Solutions
2.9.4 Kyoritsu Seiyaku Equine Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Kyoritsu Seiyaku Recent Developments and Future Plans
2.10 Vetoquinol
2.10.1 Vetoquinol Details
2.10.2 Vetoquinol Major Business
2.10.3 Vetoquinol Equine Veterinary Therapeutics Product and Solutions
2.10.4 Vetoquinol Equine Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Vetoquinol Recent Developments and Future Plans
2.11 Protexin Healthcare
2.11.1 Protexin Healthcare Details
2.11.2 Protexin Healthcare Major Business
2.11.3 Protexin Healthcare Equine Veterinary Therapeutics Product and Solutions
2.11.4 Protexin Healthcare Equine Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Protexin Healthcare Recent Developments and Future Plans
2.12 Audevard
2.12.1 Audevard Details
2.12.2 Audevard Major Business
2.12.3 Audevard Equine Veterinary Therapeutics Product and Solutions
2.12.4 Audevard Equine Veterinary Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Audevard Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Equine Veterinary Therapeutics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Equine Veterinary Therapeutics by Company Revenue
3.2.2 Top 3 Equine Veterinary Therapeutics Players Market Share in 2022
3.2.3 Top 6 Equine Veterinary Therapeutics Players Market Share in 2022
3.3 Equine Veterinary Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Equine Veterinary Therapeutics Market: Region Footprint
3.3.2 Equine Veterinary Therapeutics Market: Company Product Type Footprint
3.3.3 Equine Veterinary Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Equine Veterinary Therapeutics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Equine Veterinary Therapeutics Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Equine Veterinary Therapeutics Consumption Value Market Share by Application (2018-2023)
5.2 Global Equine Veterinary Therapeutics Market Forecast by Application (2024-2029)
6 North America
6.1 North America Equine Veterinary Therapeutics Consumption Value by Type (2018-2029)
6.2 North America Equine Veterinary Therapeutics Consumption Value by Application (2018-2029)
6.3 North America Equine Veterinary Therapeutics Market Size by Country
6.3.1 North America Equine Veterinary Therapeutics Consumption Value by Country (2018-2029)
6.3.2 United States Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
6.3.3 Canada Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
6.3.4 Mexico Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Equine Veterinary Therapeutics Consumption Value by Type (2018-2029)
7.2 Europe Equine Veterinary Therapeutics Consumption Value by Application (2018-2029)
7.3 Europe Equine Veterinary Therapeutics Market Size by Country
7.3.1 Europe Equine Veterinary Therapeutics Consumption Value by Country (2018-2029)
7.3.2 Germany Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
7.3.3 France Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
7.3.5 Russia Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
7.3.6 Italy Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Equine Veterinary Therapeutics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Equine Veterinary Therapeutics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Equine Veterinary Therapeutics Market Size by Region
8.3.1 Asia-Pacific Equine Veterinary Therapeutics Consumption Value by Region (2018-2029)
8.3.2 China Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
8.3.3 Japan Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
8.3.4 South Korea Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
8.3.5 India Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
8.3.7 Australia Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
9 South America
9.1 South America Equine Veterinary Therapeutics Consumption Value by Type (2018-2029)
9.2 South America Equine Veterinary Therapeutics Consumption Value by Application (2018-2029)
9.3 South America Equine Veterinary Therapeutics Market Size by Country
9.3.1 South America Equine Veterinary Therapeutics Consumption Value by Country (2018-2029)
9.3.2 Brazil Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
9.3.3 Argentina Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Equine Veterinary Therapeutics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Equine Veterinary Therapeutics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Equine Veterinary Therapeutics Market Size by Country
10.3.1 Middle East & Africa Equine Veterinary Therapeutics Consumption Value by Country (2018-2029)
10.3.2 Turkey Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
10.3.4 UAE Equine Veterinary Therapeutics Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Equine Veterinary Therapeutics Market Drivers
11.2 Equine Veterinary Therapeutics Market Restraints
11.3 Equine Veterinary Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Equine Veterinary Therapeutics Industry Chain
12.2 Equine Veterinary Therapeutics Upstream Analysis
12.3 Equine Veterinary Therapeutics Midstream Analysis
12.4 Equine Veterinary Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Equine Veterinary Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Equine Veterinary Therapeutics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Equine Veterinary Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Equine Veterinary Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 6. Boehringer Ingelheim Major Business
Table 7. Boehringer Ingelheim Equine Veterinary Therapeutics Product and Solutions
Table 8. Boehringer Ingelheim Equine Veterinary Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Boehringer Ingelheim Recent Developments and Future Plans
Table 10. Merck Animal Health Company Information, Head Office, and Major Competitors
Table 11. Merck Animal Health Major Business
Table 12. Merck Animal Health Equine Veterinary Therapeutics Product and Solutions
Table 13. Merck Animal Health Equine Veterinary Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Merck Animal Health Recent Developments and Future Plans
Table 15. Zoetis Company Information, Head Office, and Major Competitors
Table 16. Zoetis Major Business
Table 17. Zoetis Equine Veterinary Therapeutics Product and Solutions
Table 18. Zoetis Equine Veterinary Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Zoetis Recent Developments and Future Plans
Table 20. Elanco Animal Health Company Information, Head Office, and Major Competitors
Table 21. Elanco Animal Health Major Business
Table 22. Elanco Animal Health Equine Veterinary Therapeutics Product and Solutions
Table 23. Elanco Animal Health Equine Veterinary Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Elanco Animal Health Recent Developments and Future Plans
Table 25. Dechra Veterinary Products Company Information, Head Office, and Major Competitors
Table 26. Dechra Veterinary Products Major Business
Table 27. Dechra Veterinary Products Equine Veterinary Therapeutics Product and Solutions
Table 28. Dechra Veterinary Products Equine Veterinary Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Dechra Veterinary Products Recent Developments and Future Plans
Table 30. CEVA Company Information, Head Office, and Major Competitors
Table 31. CEVA Major Business
Table 32. CEVA Equine Veterinary Therapeutics Product and Solutions
Table 33. CEVA Equine Veterinary Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. CEVA Recent Developments and Future Plans
Table 35. Virbac Company Information, Head Office, and Major Competitors
Table 36. Virbac Major Business
Table 37. Virbac Equine Veterinary Therapeutics Product and Solutions
Table 38. Virbac Equine Veterinary Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Virbac Recent Developments and Future Plans
Table 40. Norbrook Equine Company Information, Head Office, and Major Competitors
Table 41. Norbrook Equine Major Business
Table 42. Norbrook Equine Equine Veterinary Therapeutics Product and Solutions
Table 43. Norbrook Equine Equine Veterinary Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Norbrook Equine Recent Developments and Future Plans
Table 45. Kyoritsu Seiyaku Company Information, Head Office, and Major Competitors
Table 46. Kyoritsu Seiyaku Major Business
Table 47. Kyoritsu Seiyaku Equine Veterinary Therapeutics Product and Solutions
Table 48. Kyoritsu Seiyaku Equine Veterinary Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Kyoritsu Seiyaku Recent Developments and Future Plans
Table 50. Vetoquinol Company Information, Head Office, and Major Competitors
Table 51. Vetoquinol Major Business
Table 52. Vetoquinol Equine Veterinary Therapeutics Product and Solutions
Table 53. Vetoquinol Equine Veterinary Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Vetoquinol Recent Developments and Future Plans
Table 55. Protexin Healthcare Company Information, Head Office, and Major Competitors
Table 56. Protexin Healthcare Major Business
Table 57. Protexin Healthcare Equine Veterinary Therapeutics Product and Solutions
Table 58. Protexin Healthcare Equine Veterinary Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Protexin Healthcare Recent Developments and Future Plans
Table 60. Audevard Company Information, Head Office, and Major Competitors
Table 61. Audevard Major Business
Table 62. Audevard Equine Veterinary Therapeutics Product and Solutions
Table 63. Audevard Equine Veterinary Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Audevard Recent Developments and Future Plans
Table 65. Global Equine Veterinary Therapeutics Revenue (USD Million) by Players (2018-2023)
Table 66. Global Equine Veterinary Therapeutics Revenue Share by Players (2018-2023)
Table 67. Breakdown of Equine Veterinary Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Equine Veterinary Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Equine Veterinary Therapeutics Players
Table 70. Equine Veterinary Therapeutics Market: Company Product Type Footprint
Table 71. Equine Veterinary Therapeutics Market: Company Product Application Footprint
Table 72. Equine Veterinary Therapeutics New Market Entrants and Barriers to Market Entry
Table 73. Equine Veterinary Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Equine Veterinary Therapeutics Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Equine Veterinary Therapeutics Consumption Value Share by Type (2018-2023)
Table 76. Global Equine Veterinary Therapeutics Consumption Value Forecast by Type (2024-2029)
Table 77. Global Equine Veterinary Therapeutics Consumption Value by Application (2018-2023)
Table 78. Global Equine Veterinary Therapeutics Consumption Value Forecast by Application (2024-2029)
Table 79. North America Equine Veterinary Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Equine Veterinary Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Equine Veterinary Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Equine Veterinary Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Equine Veterinary Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Equine Veterinary Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Equine Veterinary Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Equine Veterinary Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Equine Veterinary Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Equine Veterinary Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Equine Veterinary Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Equine Veterinary Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Equine Veterinary Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Equine Veterinary Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Equine Veterinary Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Equine Veterinary Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Equine Veterinary Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Equine Veterinary Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Equine Veterinary Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Equine Veterinary Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Equine Veterinary Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Equine Veterinary Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Equine Veterinary Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Equine Veterinary Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Equine Veterinary Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Equine Veterinary Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Equine Veterinary Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Equine Veterinary Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Equine Veterinary Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Equine Veterinary Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Equine Veterinary Therapeutics Raw Material
Table 110. Key Suppliers of Equine Veterinary Therapeutics Raw Materials
List of Figures
Figure 1. Equine Veterinary Therapeutics Picture
Figure 2. Global Equine Veterinary Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Equine Veterinary Therapeutics Consumption Value Market Share by Type in 2022
Figure 4. Drugs
Figure 5. Vaccine
Figure 6. Other
Figure 7. Global Equine Veterinary Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Equine Veterinary Therapeutics Consumption Value Market Share by Application in 2022
Figure 9. Veterinary Hospital Picture
Figure 10. Veterinary Clinics Picture
Figure 11. Other Picture
Figure 12. Global Equine Veterinary Therapeutics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Equine Veterinary Therapeutics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Equine Veterinary Therapeutics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Equine Veterinary Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Equine Veterinary Therapeutics Consumption Value Market Share by Region in 2022
Figure 17. North America Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Equine Veterinary Therapeutics Revenue Share by Players in 2022
Figure 23. Equine Veterinary Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Equine Veterinary Therapeutics Market Share in 2022
Figure 25. Global Top 6 Players Equine Veterinary Therapeutics Market Share in 2022
Figure 26. Global Equine Veterinary Therapeutics Consumption Value Share by Type (2018-2023)
Figure 27. Global Equine Veterinary Therapeutics Market Share Forecast by Type (2024-2029)
Figure 28. Global Equine Veterinary Therapeutics Consumption Value Share by Application (2018-2023)
Figure 29. Global Equine Veterinary Therapeutics Market Share Forecast by Application (2024-2029)
Figure 30. North America Equine Veterinary Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Equine Veterinary Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Equine Veterinary Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Equine Veterinary Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Equine Veterinary Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Equine Veterinary Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 40. France Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Equine Veterinary Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Equine Veterinary Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Equine Veterinary Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 47. China Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 50. India Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Equine Veterinary Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Equine Veterinary Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Equine Veterinary Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Equine Veterinary Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Equine Veterinary Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Equine Veterinary Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Equine Veterinary Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 64. Equine Veterinary Therapeutics Market Drivers
Figure 65. Equine Veterinary Therapeutics Market Restraints
Figure 66. Equine Veterinary Therapeutics Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Equine Veterinary Therapeutics in 2022
Figure 69. Manufacturing Process Analysis of Equine Veterinary Therapeutics
Figure 70. Equine Veterinary Therapeutics Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
